Alessandro Carrer
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
Papers in
-
- Cancer, Hypoxia, and Metabolism 8
- Oncology 9
- Pancreatic and Hepatic Oncology Research 6
- Lymphatic System and Diseases 2
- Co-authors
- Kathryn E. WellenSophie TrefelySteven ZhaoNathaniel W. SnyderJoyce V. LeeAalim M. WeljieSully FernandezAndrew J. Andrews
- Journals
- Cancer Research (2 papers)Current Opinion in Biotechnology (1 paper)Nature Genetics (1 paper)FEBS Letters (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesItalyChina
In The Last Decade
Alessandro Carrer
22 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 751
- Molecular Biology 1.4k
- Oncology 387
- Physiology 324
- Endocrinology, Diabetes and Metabolism 183
Countries citing papers authored by Alessandro Carrer
This map shows the geographic impact of Alessandro Carrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Carrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Carrer more than expected).
Fields of papers citing papers by Alessandro Carrer
This network shows the impact of papers produced by Alessandro Carrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Carrer. The network helps show where Alessandro Carrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Alessandro Carrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 67 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 30 | |
| 5 | 2021 | 4 | |
| 6 | Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate Hit paper breakdown → | 2020 | 388 |
| 7 | 2020 | 12 | |
| 8 | 2019 | 227 | |
| 9 | 2019 | 27 | |
| 10 | 2018 | 91 | |
| 11 | 2017 | 124 | |
| 12 | 2017 | 329 | |
| 13 | 2017 | 207 | |
| 14 | 2016 | 38 | |
| 15 | 2016 | 282 | |
| 16 | 2015 | 1 | |
| 17 | 2014 | 90 | |
| 18 | 2012 | 43 | |
| 19 | 2008 | 73 | |
| 20 | 2005 | 31 |
About Alessandro Carrer
Alessandro Carrer is a scholar working on Cancer Research, Oncology, Molecular Biology, Cellular and Molecular Neuroscience and Clinical Biochemistry, having authored 22 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (8 papers), Epigenetics and DNA Methylation (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), RNA modifications and cancer (5 papers), Axon Guidance and Neuronal Signaling (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Mitochondrial Function and Pathology (2 papers) and Lymphatic System and Diseases (2 papers). The work is most often cited by research in Cancer Research (751 citations), Molecular Biology (1.4k citations), Oncology (387 citations), Physiology (324 citations) and Endocrinology, Diabetes and Metabolism (183 citations). Alessandro Carrer has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Kathryn E. Wellen, Sophie Trefely, Steven Zhao, Nathaniel W. Snyder, Joyce V. Lee, Aalim M. Weljie, Sully Fernandez, Andrew J. Andrews, Luke Izzo and Sydney L. Campbell. Their work appears in journals such as Cancer Research, Current Opinion in Biotechnology, Nature Genetics, FEBS Letters and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.